<DOC>
	<DOCNO>NCT00657319</DOCNO>
	<brief_summary>This observational study conduct Europe . The objective retrospective observational cohort analysis ass change glycaemic control quality care Type 2 diabetic patient previously treat Mixtard速 insulins 6 month switch analog premix insulin NovoMix速 30 therapy .</brief_summary>
	<brief_title>Glycaemic Control Quality Care Type 2 Diabetes NovoMix速 30 Previously Treated With Mixtard速 Insulins</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin , pork ; isophane insulin , pork drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Subjects diagnose type 2 diabetes previously treat BHI least 12 month Analogue premix administration last 6 month Known suspected allergy insulin aspart Newly diagnose diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>